Study on Polycystic ovary disease

Assessing the efficacy of Homoeopathic Simillimum 200C potency in managing Polycystic Ovarian Syndrome With reference to FSH AND LH levels: A Clinical Study

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058252

Enrollment

Registered

2023-10-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N830- Follicular cyst of ovary

Interventions

Intervention1: Homoeopathic medicine: Homoeopathic medicine will be given based on the symptomatology of patients Homoeopathic medicine in 200C potency Administered orally Single dose weekly once u

Eligibility

Inclusion criteria

Inclusion criteria: Age groups : 18yrs – 40yrs Oligomenorrhoea (intermenstrual period of more than 35 days for 3 consecutive cycles/ amenorrhea for more than 3 months (2 years after menarche) Ultrasound findings of polycystic ovaries. Clinical evidence of hirsutism Females who are diagnosed with PCOS

Exclusion criteria

Exclusion criteria: Pregnant women Women using oral contraceptives or hormonal treatment Women having irreversible pathological conditions like cancer Cases with other systemic diseases

Design outcomes

Primary

Measure	Time frame
Effectiveness of Homoepathic similimum in PCOSTimepoint: Baseline, 3 months and 6 months	—

Secondary

Measure	Time frame
Will assess the effectiveness of 200C potency, USG findings and BMI scoreTimepoint: one year	—

Countries

India

Contacts

Public ContactRachana Mol S

Sarada Krishna Homoeopathic Medical College

drmmuruganhomoeo@gmail.com9443343707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026